M Visalli

1.9k total citations
32 papers, 1.6k citations indexed

About

M Visalli is a scholar working on Pharmacology, Epidemiology and Molecular Medicine. According to data from OpenAlex, M Visalli has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 18 papers in Epidemiology and 15 papers in Molecular Medicine. Recurrent topics in M Visalli's work include Antibiotics Pharmacokinetics and Efficacy (18 papers), Antibiotic Resistance in Bacteria (15 papers) and Pneumonia and Respiratory Infections (10 papers). M Visalli is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (18 papers), Antibiotic Resistance in Bacteria (15 papers) and Pneumonia and Respiratory Infections (10 papers). M Visalli collaborates with scholars based in United States. M Visalli's co-authors include Peter C. Appelbaum, Michael R. Jacobs, Patricia A. Bradford, Steven J. Projan, Charles R. Dean, Phaik‐Eng Sum, Alexey Ruzin, David Keeney, Saralee Bajaksouzian and Glenn A. Pankuch and has published in prestigious journals such as Clinical Infectious Diseases, Oncogene and Journal of Virology.

In The Last Decade

M Visalli

31 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Visalli United States	20	946	613	538	370	292	32	1.6k
Wenchi Shang United States	18	876 0.9×	462 0.8×	462 0.9×	266 0.7×	344 1.2×	22	1.3k
Fernando Docobo-Pérez Spain	25	1.1k 1.1×	534 0.9×	482 0.9×	331 0.9×	204 0.7×	65	1.5k
María‐Isabel Morosini Spain	26	946 1.0×	295 0.5×	446 0.8×	459 1.2×	259 0.9×	55	1.6k
Jennifer Adams United States	12	955 1.0×	273 0.4×	375 0.7×	365 1.0×	188 0.6×	13	1.3k
Binghua Hao United States	23	1.2k 1.3×	927 1.5×	590 1.1×	335 0.9×	374 1.3×	29	1.8k
Steven H. Marshall United States	20	994 1.1×	346 0.6×	288 0.5×	333 0.9×	293 1.0×	60	1.3k
Qinglan Guo China	23	1.3k 1.3×	378 0.6×	446 0.8×	319 0.9×	215 0.7×	57	1.6k
María Eugenia Pachón-Ibáñez Spain	23	1.0k 1.1×	410 0.7×	330 0.6×	521 1.4×	191 0.7×	65	1.6k
Qiwen Yang China	22	1.2k 1.2×	413 0.7×	380 0.7×	321 0.9×	199 0.7×	82	1.7k
María F. Mojica United States	18	901 1.0×	339 0.6×	322 0.6×	466 1.3×	410 1.4×	56	1.5k

Countries citing papers authored by M Visalli

Since Specialization

Citations

This map shows the geographic impact of M Visalli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Visalli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Visalli more than expected).

Fields of papers citing papers by M Visalli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Visalli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Visalli. The network helps show where M Visalli may publish in the future.

Co-authorship network of co-authors of M Visalli

This figure shows the co-authorship network connecting the top 25 collaborators of M Visalli. A scholar is included among the top collaborators of M Visalli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Visalli. M Visalli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Visalli, Robert J., et al.. (2019). Identification of the Epstein Barr Virus portal. Virology. 529. 152–159. 10 indexed citations

Visalli, M, et al.. (2014). The Varicella-Zoster Virus Portal Protein Is Essential for Cleavage and Packaging of Viral DNA. Journal of Virology. 88(14). 7973–7986. 15 indexed citations

Sherman, Debra M., et al.. (2012). The Varicella-zoster virus ORF54 gene product encodes the capsid portal protein, pORF54. Virus Research. 167(1). 102–105. 9 indexed citations

Visalli, Robert J., et al.. (2009). Characterization of the Varicella-zoster virus ORF25 gene product: pORF25 interacts with multiple DNA encapsidation proteins. Virus Research. 144(1-2). 58–64. 12 indexed citations

Visalli, Robert J., et al.. (2007). The Varicella-zoster virus DNA encapsidation genes: Identification and characterization of the putative terminase subunits. Virus Research. 129(2). 200–211. 13 indexed citations

Ruzin, Alexey, M Visalli, David Keeney, & Patricia A. Bradford. (2005). Influence of Transcriptional Activator RamA on Expression of Multidrug Efflux Pump AcrAB and Tigecycline Susceptibility in Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 49(3). 1017–1022. 168 indexed citations

Bouchillon, S., Brian Johnson, D. Hoban, et al.. (2004). Determining incidence of extended spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001–2002. International Journal of Antimicrobial Agents. 24(2). 119–124. 123 indexed citations

Visalli, M, Ellen Murphy, Steven J. Projan, & Patricia A. Bradford. (2003). AcrAB Multidrug Efflux Pump Is Associated with Reduced Levels of Susceptibility to Tigecycline (GAR-936) in Proteus mirabilis. Antimicrobial Agents and Chemotherapy. 47(2). 665–669. 138 indexed citations

Rossman, Toby G., M Visalli, & Elena V. Komissarova. (2003). fau and its ubiquitin-like domain (FUBI) transforms human osteogenic sarcoma (HOS) cells to anchorage-independence. Oncogene. 22(12). 1817–1821. 23 indexed citations

10.

Dean, Charles R., M Visalli, Steven J. Projan, Phaik‐Eng Sum, & Patricia A. Bradford. (2003). Efflux-Mediated Resistance to Tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1. Antimicrobial Agents and Chemotherapy. 47(3). 972–978. 237 indexed citations

11.

Quale, John, et al.. (2002). Molecular Epidemiology of a Citywide Outbreak of Extended‐Spectrum β‐Lactamase–Producing Klebsiella pneumoniae Infection. Clinical Infectious Diseases. 35(7). 834–841. 82 indexed citations

12.

Visalli, M, Saralee Bajaksouzian, Michael R. Jacobs, & Peter C. Appelbaum. (1998). Synergistic Activity of Trovafloxacin with Other Agents Against Gram-positive and -negative Organisms. Diagnostic Microbiology and Infectious Disease. 30(1). 61–64. 4 indexed citations

13.

Visalli, M, Michael R. Jacobs, & Peter C. Appelbaum. (1997). Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill. Diagnostic Microbiology and Infectious Disease. 28(3). 131–137. 10 indexed citations

14.

Bajaksouzian, Saralee, M Visalli, Michael R. Jacobs, & Peter C. Appelbaum. (1997). Activities of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with amikacin, against acinetobacters as determined by checkerboard and time-kill studies. Antimicrobial Agents and Chemotherapy. 41(5). 1073–1076. 69 indexed citations

15.

Visalli, M, Michael R. Jacobs, & Peter C. Appelbaum. (1996). Activity of CP 99,219 (trovafloxacin) compared with ciprofloxacin, sparfloxacin, clinafloxacin, lomefloxacin and cefuroxime against ten penicillin-susceptible and pencillin-resistant pneumococci by time-kill methodology. Journal of Antimicrobial Chemotherapy. 37(1). 77–84. 27 indexed citations

16.

Ednie, Lois M., M Visalli, Michael R. Jacobs, & Peter C. Appelbaum. (1996). Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. Antimicrobial Agents and Chemotherapy. 40(8). 1950–1952. 37 indexed citations

17.

Bajaksouzian, Saralee, M Visalli, Michael R. Jacobs, & Peter C. Appelbaum. (1996). Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods. Antimicrobial Agents and Chemotherapy. 40(9). 1973–1976. 30 indexed citations

18.

Visalli, M, Michael R. Jacobs, & Peter C. Appelbaum. (1996). MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci. Antimicrobial Agents and Chemotherapy. 40(2). 362–366. 54 indexed citations

19.

Pankuch, Glenn A., M Visalli, Michael R. Jacobs, & Peter C. Appelbaum. (1995). Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci. Antimicrobial Agents and Chemotherapy. 39(7). 1499–1504. 17 indexed citations

20.

Doctor, John S., et al.. (1992). Sequence, biochemical characterization, and developmental expression of a new member of the TGF-β superfamily in Drosophila melanogaster. Developmental Biology. 151(2). 491–505. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact